Healthy Skepticism Library item: 6435

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

McCarthy M.
Bromocriptine not for lactation suppression
Lancet 1994; 344:602

Abstract:

The Health Research Group filed suit against the Food and Drug Administration to force the FDA to withdraw postpartum lactation suppression as an indication for the use of Parlodel (bromocriptine). The next day the FDA announced that it would move to withdraw the indication and the following day Sandoz announced that it was voluntarily withdrawing the indication.

Keywords:
*news story/United States/Sandoz/Parlodel/Health Research Group/FDA/Food and Drug Administration/health and healthcare/INFLUENCE OF PROMOTION: HEALTH AND HEALTH CARE